CS logo
small CS logo
Virginia Oncology Associates

Norfolk, Virginia, United States
Oncologist in Norfolk, Virginia
6251 E Virginia Beach Blvd Suite 200, Norfolk, VA 23502

About Virginia Oncology Associates


"Virginia Oncology Associates is an oncology and hematology practice of physicians, specializing in the diagnosis and treatment of cancer and blood disorders. With locations spanning the southeast region of Virginia and Northeastern North Carolina, we are able to extend services and treatments to patients, including medical oncology, radiation oncology, gynecologic oncology, hematology, diagnostics, clinical research, stem cell transplantation, genetic counseling, and psychosocial oncology."
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
US Oncology Research
15
Hoffmann-La Roche
14
Pfizer
13
Novartis Pharmaceuticals
9
Janssen Research & Development, LLC
7
Bristol-Myers Squibb
6
Celgene
6
Eisai Inc.
5
Gilead Sciences
5
Amgen
4
G1 Therapeutics, Inc.
4
Total Rows: 87

Clinical Trials at Virginia Oncology Associates


During the past decade, Virginia Oncology Associates conducted 80 clinical trials. In the 10-year time frame, 80 clinical trials started and 64 clinical trials were completed, i.e. on average, 80% percent of trials that started reached the finish line to date. In the past 5 years, 33 clinical trials started and 26 clinical trials were completed. i.e. 78.8% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1111221414111199131315155500191955777744111155Started TrialsCompleted Trails2015201620172018201920202021202201020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
1998-07-01
2002-09-01
Completed
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
2002-06-01
2006-01-01
Completed
865
Clinical Trial for Ovarian Cancer (OvaRex®)
2002-12-01
2007-12-01
Terminated
354
Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer
2002-05-01
2005-03-01
Completed
612
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Previously Treated Metastatic Colorectal Cancer
2003-01-01
2007-01-01
Completed
855
Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer.
2003-02-01
Completed
1,168
Safety Study Using Weekly Infusions of BB-10901 in Patients With Small Cell Lung Cancer
2003-04-01
2008-12-01
Completed
64
Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen
2003-09-01
2007-03-01
Completed

Rows per page:

1–100 of 193

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Virginia Oncology Associates" #1 sponsor was "US Oncology Research" with 15 trials, followed by "Hoffmann-La Roche" with 14 trials sponsored, "Pfizer" with 13 trials sponsored, "Novartis Pharmaceuticals" with 9 trials sponsored and "Janssen Research & Development, LLC" with 9 trials sponsored. Other sponsors include 130 different institutions and companies that sponsored additional 87 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Virginia Oncology Associates" #1 collaborator was "Bristol-Myers Squibb" with 8 trials as a collaborator, "Sanofi" with 8 trials as a collaborator, "Merck Sharp & Dohme LLC" with 6 trials as a collaborator, "Astellas Pharma Inc" with 5 trials as a collaborator and "Hoosier Cancer Research Network" with 5 trials as a collaborator. Other collaborators include 68 different institutions and companies that were collaborators in the rest 58 trials.
Created with Highcharts 11.1.0Top Leading SponsorsUS Oncology Research: 15US Oncology Research: 15Hoffmann-La Roche: 14Hoffmann-La Roche: 14Pfizer: 13Pfizer: 13Novartis Pharmaceuticals: 9Novartis Pharmaceuticals: 9Janssen Research &Development, LLC: 7Janssen Research &Development, LLC: 7Bristol-Myers Squibb: 6Bristol-Myers Squibb: 6Celgene: 6Celgene: 6Eisai Inc.: 5Eisai Inc.: 5Gilead Sciences: 5Gilead Sciences: 5Amgen: 4Amgen: 4

Created with Highcharts 11.1.0Top CollaboratorsBristol-Myers Squibb: 8Bristol-Myers Squibb: 8Sanofi: 8Sanofi: 8Merck Sharp & Dohme LLC: 6Merck Sharp & Dohme LLC: 6Astellas Pharma Inc: 5Astellas Pharma Inc: 5Hoosier CancerResearch Network: 5Hoosier CancerResearch Network: 5Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:5Medivation LLC, awholly ownedsubsidiary of Pfizer Inc.:5Pfizer: 4Pfizer: 4Eli Lilly and Company: 3Eli Lilly and Company: 3European Network ofGynaecologicalOncological Trial Groups(ENGOT): 3European Network ofGynaecologicalOncological Trial Groups(ENGOT): 3GOG Foundation: 3GOG Foundation: 3

Clinical Trials Conditions at Virginia Oncology Associates


According to Clinical.Site data, the most researched conditions in "Virginia Oncology Associates" are "Breast Cancer" (19 trials), "Prostate Cancer" (19 trials), "Metastatic Breast Cancer" (14 trials), "Ovarian Cancer" (10 trials) and "Multiple Myeloma" (6 trials). Many other conditions were trialed in "Virginia Oncology Associates" in a lesser frequency.

Clinical Trials Intervention Types at Virginia Oncology Associates


Most popular intervention types in "Virginia Oncology Associates" are "Drug" (184 trials), "Biological" (10 trials), "Other" (10 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (23 trials), "Paclitaxel" (20 trials), "Carboplatin" (13 trials), "Gemcitabine" (13 trials) and "Docetaxel" (12 trials). Other intervention names were less common.

Clinical Trials Genders at Virginia Oncology Associates


The vast majority of trials in "Virginia Oncology Associates" are 127 trials for "All" genders, 33 trials for "Male" genders and 31 trials for "Female" genders.

Clinical Trials Status at Virginia Oncology Associates


Currently, there are NaN active trials in "Virginia Oncology Associates". undefined are not yet recruiting, 22 are recruiting, 31 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 108 completed trials in Virginia Oncology Associates, undefined suspended trials, and 28 terminated clinical trials to date.
Out of the total trials that were conducted in Virginia Oncology Associates, 47 "Phase 1" clinical trials were conducted, 74 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 81Phase 3: 81Phase 2: 74Phase 2: 74Phase 1: 47Phase 1: 47Not Applicable: 1Not Applicable: 1Phase 4: 1Phase 4: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 108Completed: 108Active, not recruiting: 31Active, not recruiting: 31Terminated: 28Terminated: 28Recruiting: 22Recruiting: 22Withdrawn: 2Withdrawn: 2No longer available: 1No longer available: 1Unknown status: 1Unknown status: 1

Departments of Virginia Oncology Associates


Virginia Oncology Associates has several departments that took part in Clinical trials: "Virginia Oncology Associates-Hampton" - 56 trials, "Virginia Oncology Associates" - 2 trials, "Virginia Oncology Associates - Norfolk" - 28 trials, "Virginia Oncology Associates - Lake Wright" - 21 trials, "Hematology & Oncology Associates of Virginia" - 4 trials